A closely watched trial over Idaho’s near-total abortion ban continues Tuesday

In the past few weeks, Lon­za has an­nounced sev­er­al new fa­cil­i­ty builds, from its part­ner­ship with Ver­tex Phar­ma­ceu­ti­cals on a new cell and gene ther­a­py

Met­sera, the well-fund­ed obe­si­ty biotech from Pop­u­la­tion Health Part­ners and ARCH Ven­ture Part­ners, has un­veiled its first clin­i­cal da­ta just a few months af­ter emerg­ing